Related references
Note: Only part of the references are listed.Efficacy and safety of fibrinogen concentrate for on-demand treatment of bleeding and surgical prophylaxis in paediatric patients with congenital fibrinogen deficiency
Claudia Djambas Khayat et al.
HAEMOPHILIA (2021)
Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients
Toshko Lissitchkov et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Pharmacology, Efficacy and Safety of a Triple-Secured Fibrinogen Concentrate in Children Less than or Equal to 12 Years with Afibrinogenaemia
Claudia Djambas Khayat et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency
Fang Dong et al.
WORLD JOURNAL OF CLINICAL CASES (2019)
Clinical pharmacology, efficacy and safety study of a triple-secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiency
Claudia Djambas Khayat et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Postauthorization safety study of Clottafact®, a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study
C. Negrier et al.
VOX SANGUINIS (2018)
Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency
C. Ross et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH
A. Casini et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Thrombosis in Inherited Fibrinogen Disorders
Wolfgang Korte et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2017)
Post-authorization safety study of Clottafact®, a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study
C. Negrier et al.
VOX SANGUINIS (2016)
Early prophylactic anticoagulation for portal vein system thrombosis after splenectomy: A systematic review and meta-analysis
Ning Zhang et al.
BIOMEDICAL REPORTS (2016)
Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia
Jingyi Zhou et al.
BLOOD CELLS MOLECULES AND DISEASES (2015)
Guideline for the diagnosis and management of the rare coagulation disorders A United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology
Andrew D. Mumford et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Fibrinogen replacement therapy for congenital fibrinogen deficiency
L. Bornikova et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults
Eva Fernandez et al.
Pharmaceutics (2011)
A critical evaluation of cryoprecipitate for replacement of fibrinogen
Benny Sorensen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia
F. Peyvandi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency
W Kreuz et al.
TRANSFUSION AND APHERESIS SCIENCE (2005)
Share Paper
